Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07186725 · ClinicalTrials.gov registry record · NA
Home-based Under Mattress Monitor for OSA
A NA study of Obstructive Sleep Apnea (OSAS) and Obstructive Sleep Apnea (SAOS), sponsored by Isabel Moreno Hay.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07186725: Recruiting NA study of Obstructive Sleep Apnea (OSAS) and Obstructive Sleep Apnea (SAOS), sponsored by Isabel Moreno Hay.
NCT07186725 is a NA study of Obstructive Sleep Apnea (OSAS) and Obstructive Sleep Apnea (SAOS) that is actively recruiting participants, run by Isabel Moreno Hay. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07186725, a NA study of Obstructive Sleep Apnea (OSAS) and Obstructive Sleep Apnea (SAOS), is actively recruiting participants, sponsored by Isabel Moreno Hay.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's satisfaction with MAD. A third aim is to analyze if there are differences between the sleep parameters recorded by the under-mattress monitor between responders and non-responders to MAD therapy.
Primary Outcome
Number of apneas and hypopneas per hour of sleep which is an indicator of severity of sleep apnea, (5\< normal, 5-15 Mild, 15-30 moderate, \<30 severe)
Conditions Studied
Interventions
- DEVICE Under-mattress monitor
- DEVICE level 3 Home Sleep Apnea Test
- DEVICE Mandibular Advancement Device (MAD)
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT07186725 shows while recruiting
NCT07186725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Obstructive Sleep Apnea (OSAS) appearing as the primary indexed condition, and to 3 interventions - of which Under-mattress monitor is the first listed.
NCT07186725 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07186725 about?
NCT07186725 is a clinical study titled "Home-based Under Mattress Monitor for OSA". The aim of the study is to evaluate the effectiveness of the under-mattress monitoring device to aid in the titration process of a mandibular advancement device (MAD) for the management of obstructive sleep apnea (OSA). A secondary aim is to evaluate changes in subjective OSA symptoms and patient's ...
What is the current status of trial NCT07186725?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-01-07. Estimated completion is 2027-03.
What conditions does trial NCT07186725 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSAS), Obstructive Sleep Apnea (SAOS).
What interventions are being tested in trial NCT07186725?
The interventions under investigation include: Under-mattress monitor (DEVICE), level 3 Home Sleep Apnea Test (DEVICE), Mandibular Advancement Device (MAD) (DEVICE).
Who is sponsoring clinical trial NCT07186725?
This trial is sponsored by Isabel Moreno Hay, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07186725 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07186725's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI